Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-0.97%Buyback Yield
VS
Market
Sector
Industry
History
$ 0.15Close
$ 0.15 - $ 1.11 52-Week Range
Ticker Information
Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARISMA THERAPEUTICS INC - Buyback Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CARM - Buyback Yield Historical data
| Date | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|---|---|
| 6/30/2025 | -0.97% | $ 11.49M | $ 111K |
| 3/31/2025 | -1.45% | $ 7.77M | $ 113K |
| 12/31/2024 | -18.5% | $ 12.95M | $ 2.4M |
| 9/30/2024 | -7.23% | $ 43M | $ 3.11M |
| 6/30/2024 | -8.07% | $ 37.43M | $ 3.02M |
| 3/31/2024 | -4.9% | $ 62.73M | $ 3.07M |
| 12/31/2023 | -36.19% | $ 86.82M | $ 31.42M |
| 9/30/2023 | -28.79% | $ 106.74M | $ 30.73M |
| 6/30/2023 | -12.85% | $ 238.89M | $ 30.69M |
| 3/31/2023 | -13.47% | $ 227.44M | $ 30.64M |
Key Performance Insights, Last 5 Years
- CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) Buyback Yield stands at -14.1%.
- Over the past 5 years, CARISMA THERAPEUTICS INC's average Buyback Yield has been -27.99%.
- The median Buyback Yield for CARISMA THERAPEUTICS INC during this period was -13.79%
- CARISMA THERAPEUTICS INC reached its highest Buyback Yield over the past 5 years at 0%.
- The lowest Buyback Yield recorded by CARISMA THERAPEUTICS INC in the same timeframe -139.21%
CARISMA THERAPEUTICS INC's Buyback Yield vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Buyback Yield Benchmarks
Similar metrics to CF - Equity:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
Definition of Buyback Yield
[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.(-1 * CF - Equity) / Market Cap
(=) Buyback Yield Buyback Yield for CARISMA THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 20.24M ]) / Market Cap [ $ 143.57M ]
(=) Buyback Yield [ -14.1% ] CARM - Buyback Yield, Last 5 years
-139.21%
Minimum
Dec 31, 2021
0%
Maximum
Dec 31, 2022
-27.99%
Average
-13.79%
Median
Buyback Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -8.43% |
| max | 8.43% |
| average | 0.64% |
| median | 0.01% |
| std | 2.71% |